103 related articles for article (PubMed ID: 38734499)
1. Burden of Infection in Patients With and Without Secondary Immunodeficiency Disease Following Diagnosis of a Mature B Cell Malignancy.
Richter J; Davids MS; Anderson-Smits C; Kamieniak M; Ren K; Hull M; Multani JK; Shah D; Siffel C
Clin Lymphoma Myeloma Leuk; 2024 Apr; ():. PubMed ID: 38734499
[TBL] [Abstract][Full Text] [Related]
2. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
3. Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review.
Jolles S; Giralt S; Kerre T; Lazarus HM; Mustafa SS; Ria R; Vinh DC
Front Oncol; 2023; 13():1098326. PubMed ID: 36824125
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Current Approach in the Management of Secondary Immunodeficiency in Patients with Hematological Malignancies: Spanish Expert Consensus Recommendations.
Boqué C; Sánchez-Ramón S; Córdoba R; Moreno C; Cabezudo E
J Clin Med; 2023 Oct; 12(19):. PubMed ID: 37835000
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignancies.
Jolles S; Smith BD; Vinh DC; Mallick R; Espinoza G; DeKoven M; Divino V
Leuk Lymphoma; 2022 Jan; 63(1):64-73. PubMed ID: 34702119
[TBL] [Abstract][Full Text] [Related]
7. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
8. Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies.
Na IK; Buckland M; Agostini C; Edgar JDM; Friman V; Michallet M; Sánchez-Ramón S; Scheibenbogen C; Quinti I
Eur J Haematol; 2019 Jun; 102(6):447-456. PubMed ID: 30801785
[TBL] [Abstract][Full Text] [Related]
9. Secondary Immunodeficiency and Hypogammaglobulinemia with IgG Levels of <5 g/L in Patients with Multiple Myeloma: A Retrospective Study Between 2012 and 2020 at a University Hospital in China.
Ye C; Chen W; Gao Q; Chen Y; Song X; Zheng S; Liu J
Med Sci Monit; 2021 Jul; 27():e930241. PubMed ID: 34238914
[TBL] [Abstract][Full Text] [Related]
10. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
[TBL] [Abstract][Full Text] [Related]
11. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study.
Cerhan JR; Janney CA; Vachon CM; Habermann TM; Kay NE; Potter JD; Sellers TA; Folsom AR
Am J Epidemiol; 2002 Sep; 156(6):527-35. PubMed ID: 12226000
[TBL] [Abstract][Full Text] [Related]
12. Infections in secondary immunodeficiency patients treated with Privigen
Mallick R; Divino V; Smith BD; Jolles S; DeKoven M; Vinh DC
Leuk Lymphoma; 2021 Dec; 62(14):3463-3473. PubMed ID: 34569910
[TBL] [Abstract][Full Text] [Related]
13. Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition.
Khan AE; Gallo V; Linseisen J; Kaaks R; Rohrmann S; Raaschou-Nielsen O; Tjønneland A; Johnsen HE; Overvad K; Bergmann MM; Boeing H; Benetou V; Psaltopoulou T; Trichopoulou A; Masala G; Mattiello A; Grioni S; Tumino R; Vermeulen RC; Peeters PH; Bueno-de-Mesquita HB; Ros MM; Lund E; Ardanaz E; Chirlaque MD; Jakszyn P; Larrañaga N; Losada A; Becker N; Nieters A; Martínez-García C; Agren A; Hallmans G; Berglund G; Manjer J; Allen NE; Key TJ; Bingham S; Khaw KT; Slimani N; Ferrari P; Boffetta P; Norat T; Vineis P; Riboli E;
Haematologica; 2008 Jun; 93(6):842-50. PubMed ID: 18443270
[TBL] [Abstract][Full Text] [Related]
14. Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives.
Ar MC; El Fakih R; Gabbassova S; Alhuraiji A; Nasr F; Alsaeed A; Sayinalp N; Marashi M
Leuk Res; 2023 Oct; 133():107365. PubMed ID: 37643508
[TBL] [Abstract][Full Text] [Related]
15. [Hypogammaglobulinemia and immunodeficiency in multiple myeloma and chronic lymphoid leukemia].
Matthes T; Jandus P
Rev Med Suisse; 2023 Apr; 19(821):668-673. PubMed ID: 37017348
[TBL] [Abstract][Full Text] [Related]
16. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
[TBL] [Abstract][Full Text] [Related]
17. Head and neck squamous cell cancer associated with lymphoproliferative malignancies is aggressive.
Li L; Hamilton L; Montgomery J; Stewart M
J Laryngol Otol; 2020 May; 134(5):460-462. PubMed ID: 32308160
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
19. Reduced risk of infections with the intravenous immunoglobulin, IgPro10, in patients at risk of secondary immunodeficiency-related infections.
Lahue BJ; Mallick R; Zhang X; Heidt J; Song Y; Koenig AS; Espinoza G
Immunotherapy; 2022 Oct; 14(15):1245-1261. PubMed ID: 35971794
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center study.
Marchesi F; Pimpinelli F; Gumenyuk S; Renzi D; Palombi F; Pisani F; Romano A; Spadea A; Papa E; Canfora M; Ensoli F; Mengarelli A
World J Transplant; 2015 Sep; 5(3):129-36. PubMed ID: 26421265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
